Symptomtext
No additional adverse event reported; MMR II and VARIVAX were administered to a patient after tenperature excursion; This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported. On 05-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (Lot# U015846 and expiration date 19-MAY-2023) (exact dose and frequency were not reported) as prophylaxis. The vaccine a temperature excursion and time frame were unknown. There was no previous temperature excursion. The patient also vaccinated on 05-JAN-2022 with improperly stored measles, mumps, and rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) Lot# T033814 and expiration date 05-OCT-2022) (exact dose and frequency were not reported) as prophylaxis (product storage error). The vaccine underwent a temperature excursion of 47.5 Fahrenheit for 1 hours. There was no previous temperature excursion. No additional adverse event reported.